Peifen Fu
- Topics
- HER2/EGFR in Cancer Research (4 papers)Cancer Treatment and Pharmacology (3 papers)Breast Cancer Treatment Studies (3 papers)
- Journals
- Journal of Clinical OncologyBiochemical and Biophysical Research CommunicationsScience Advances
- Partner nations
- ChinaUnited States
In The Last Decade
Peifen Fu
15 papers receiving 386 citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 214
- Molecular Biology 135
- Cancer Research 97
- Immunology 93
- Pulmonary and Respiratory Medicine 45
Countries citing papers authored by Peifen Fu
This map shows the geographic impact of Peifen Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peifen Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peifen Fu more than expected).
Fields of papers citing papers by Peifen Fu
This network shows the impact of papers produced by Peifen Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peifen Fu. The network helps show where Peifen Fu may publish in the future.
Co-authorship network of co-authors of Peifen Fu
This figure shows the co-authorship network connecting the top 25 collaborators of Peifen Fu. A scholar is included among the top collaborators of Peifen Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peifen Fu. Peifen Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 4 | |
| 5 | 0 | |
| 6 | Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implicationsbreakdown → | 100 |
| 7 | 2 | |
| 8 | 1 | |
| 9 | 9 | |
| 10 | 48 | |
| 11 | 20 | |
| 12 | 58 | |
| 13 | 1 | |
| 14 | 75 | |
| 15 | 27 | |
| 16 | 22 | |
| 17 | 5 | |
| 18 | Symptomatic adult annular pancreas: report of two cases and a review of the literature. | 17 |
| 19 | [Orthotopic liver transplantation with no veno-venous bypass]. | 1 |
About Peifen Fu
Peifen Fu is a scholar working on Oncology, Cancer Research and Transplantation, having authored 19 papers that have together received 390 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (4 papers), Cancer Treatment and Pharmacology (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Oncology (214 citations), Cancer Research (97 citations) and Geriatrics and Gerontology (18 citations). Peifen Fu has collaborated with scholars based in China and United States. Frequent co-authors include Minya Yao, Shuqian Wang, Weimin Fan, Chengyong Du, Yue Lu, Yuexin Lu, Kezhen Lv, Weilin Wang, Yinan Yao and Yu Liu. Their work appears in journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Science Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.